Imexpharm Corporation

IMP

VN000000IMP0

Pharmaceuticals

End-of-day quote Ho Chi Minh S.E. Other stock markets 06:00:00 2024-04-25 pm EDT			5-day change	1st Jan Change
64,500 ^VND	-0.92%		-6.93%	+13.96%

Apr. 19	Imexpharm Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Jan. 19	Imexpharm Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	CI

Imexpharm Corporation Provides Earnings Guidance for the Fourth Quarter and Full Year of 2020

October 29, 2020 at 05:30 am EDT

Imexpharm Corporation provided earnings guidance for the fourth quarter and full year of 2020. For the quarter, the company expects total revenue to be of VND 488.6 billion. For the year, the company expects total revenue to be of VND 1,400.2 billion.

Latest news about Imexpharm Corporation

Imexpharm Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 18	CI
Imexpharm Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Jan. 19	CI
Imexpharm Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	Jan. 19	CI
Imexpharm Corporation Approves Election of Hoang Duc Hung as an Independent Member of the Board of Directors	Dec. 19	CI
Imexpharm Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	23-10-18	CI
Imexpharm Corporation Announces Dividend, Payable on October 20, 2023	23-09-18	CI
Imexpharm Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-07-18	CI
Imexpharm Corporation Appoints Chun Chaerhan as Chairperson of the Board of Directors	23-05-04	CI
Imexpharm Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-18	CI
Imexpharm Corporation Reports Earnings Results for the Full Year Ended December 31, 2022	23-01-17	CI
Imexpharm Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	23-01-17	CI
Imexpharm Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-10-18	CI
Imexpharm Corporation announced that it has received funding from SK Group Ltd.	22-08-24	CI
Imexpharm Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-07-18	CI
Imexpharm Corporation Announces Personnel Change	22-05-30	CI
Imexpharm Corporation Announces Cash Dividend for 2021, Payable on June 24, 2022	22-05-13	CI
Imexpharm Corporation Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-18	CI
Imexpharm Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2021	22-01-20	CI
Imexpharm Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-10-18	CI
Imexpharm Corporation Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-07-20	CI
Imexpharm Corporation Reports Earnings Results for the First Quarter Ended March 31, 2021	21-04-18	CI
Imexpharm Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2020	21-01-19	CI
Imexpharm Corporation Reports Earnings Results for the Nine Months of 2020	20-10-29	CI
Imexpharm Corporation Provides Earnings Guidance for the Fourth Quarter and Full Year of 2020	20-10-29	CI
Imexpharm Corporation Reports Earnings Results for the Six Months of 2020	20-08-13	CI

Chart Imexpharm Corporation

Duration

Period

More charts

Company Profile

Imexpharm Corporation is a Vietnam-based company engaged in the pharmaceutical industry. The Company manufactures, imports, exports and trades pharmaceutical products, antiseptics, traditional medicine, medical equipment and supplies, cosmetics, supplemental food and drinks. It is also involved in the provision of packaging services and warehousing services for pharmaceutical storage purposes. In addition, the Company is involved in medicinal herb cultivation.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

64,500 VND

Average target price

77,033 VND

Spread / Average Target

+19.43%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
IMEXPHARM CORPORATION	+13.96%	178M
ELI LILLY AND COMPANY	+26.07%	661B
NOVO NORDISK A/S	+26.74%	566B
JOHNSON & JOHNSON	-6.46%	352B
MERCK & CO., INC.	+18.74%	332B
ABBVIE INC.	+3.83%	283B
ASTRAZENECA PLC	+13.43%	231B
NOVARTIS AG	+4.71%	200B
ROCHE HOLDING AG	-9.53%	195B
AMGEN INC.	-4.09%	145B

Other Pharmaceuticals